Aspiriant LLC’s Vanguard Russell 1000 ETF VONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$287K Buy
835
+200
+31% +$68.8K 0.01% 328
2026
Q2
$215K Buy
+635
New +$208K 0.01% 371
2015
Q4
– Sell
-2,498
Closed -$238K – 100
2015
Q3
$238K Hold
2,498
– – 0.02% 96
2015
Q2
$238K Buy
+2,498
New +$243K 0.02% 100
2014
Q4
– Sell
-5,260
Closed -$478K – 99
2014
Q3
$478K Sell
5,260
-6,974
-57% -$636K 0.07% 59
2014
Q2
$1.11M Sell
12,234
-3,928
-24% -$345K 0.15% 40
2014
Q1
$1.4M Buy
+16,162
New +$1.37M 0.2% 36

Other funds holding VONE

Aspiriant LLC's VONE Position: Q3 2026 in Review

Aspiriant LLC increased its Vanguard Russell 1000 ETF (VONE) stake by 31% in Q3 2026, buying an estimated $68.8K and bringing the position to 835 shares worth $287K. The position accounts for 0.01% of the portfolio, ranked #328.

Aspiriant LLC first reported a position in VONE in Q1 2014 and has held it in 7 quarters since. The position peaked at $1.4M in Q1 2014. 111 funds tracked by Wall St. Rank hold VONE as of Q3 2026.

  • Aspiriant LLC held 835 shares of Vanguard Russell 1000 ETF worth $287K as of Q3 2026.
  • Aspiriant LLC bought 200 Vanguard Russell 1000 ETF shares in Q3 2026, an estimated $68.8K.
  • Vanguard Russell 1000 ETF made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #328 holding.
  • Aspiriant LLC first reported a position in Vanguard Russell 1000 ETF in Q1 2014 and has held it in 7 quarters since.
  • Aspiriant LLC's Vanguard Russell 1000 ETF position peaked at $1.4M in Q1 2014.
  • 111 funds tracked by Wall St. Rank held Vanguard Russell 1000 ETF as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.